drug

LOS ANGELES, CALIFORNIA - APRIL 17: In this photo illustration, boxes of the diabetes drug Ozempic rest on a drugstore counter on April 17, 2023 in Los Angeles, California.  Ozempic was originally approved by the FDA to treat people with type 2 diabetes, who risk serious health consequences without medication.  In recent months, there has been a spike in demand for Ozempic, or semaglutide, due to its weight-loss benefits, which has led to shortages.  Some doctors prescribe Ozempic off-label to treat obesity.  (Photo illustration by Mario Tama/Getty Images)

Ozempic users report stomach paralysis from diet drug: ‘So much hell’

Photo illustration by Mario Tama/Getty Images Since Ozempic was first released to the public in 2018, the diabetic injectable has become a favorite for fans, even those without diabetes, for weight loss. Others in its class of drugs, such as Wegovy, have also seen an increase in demand, so high that the Food and Drug …

Ozempic users report stomach paralysis from diet drug: ‘So much hell’ Read More »

Griselda Martinez, mayor of Manzanillo

How fentanyl changed the game for Mexican drug cartels

One Sunday morning in May, after leaving a restaurant in western Mexico, Sergio Emmanuel Martnez, the new customs director of the country’s largest port, was kidnapped. The next day, he was found dead alongside a highway, making him the fourth Port of Manzanillo customs official to be murdered in less than two years. Manzanillo is …

How fentanyl changed the game for Mexican drug cartels Read More »

Lexapro for children: drug without significant benefits and increase in suicide gets FDA approval

In May, the FDA expanded the approval of drug giant AbbVie’s SSRI escitalopram (Lexapro) to include children ages seven and older who suffer from anxiety. The basis for the approval was a clinical trial conducted by AbbVie employees, with an article written by AbbVie’s ghostwriting company. Researchers randomly assigned 275 children aged 7 to 17 …

Lexapro for children: drug without significant benefits and increase in suicide gets FDA approval Read More »

Tornado damage to the Pfizer facility may exacerbate drug shortages

Tornado damage to the Pfizer facility may exacerbate drug shortages

Albert Bourla, CEO of Pfizer. Lintao Zhang/Getty Images Hospital drug buyers are trying to figure out how tornado damage at a major Pfizer manufacturing facility will affect drug availability across the country at a time of record drug shortages. Healthcare providers Premier Inc. and Vizient Inc. said they are working with other drugmakers to see …

Tornado damage to the Pfizer facility may exacerbate drug shortages Read More »

Blockbuster drug Humira finally faces low-cost rivals

Blockbuster drug Humira finally faces low-cost rivals

AbbVie’s Humira was the world’s best-selling drug for many years. It now faces competition for knockoffs that cost a fraction of its price. David J. Philip/AP hide caption toggle caption on/off David J. Philip/AP AbbVie’s Humira was the world’s best-selling drug for many years. It now faces competition for knockoffs that cost a fraction of …

Blockbuster drug Humira finally faces low-cost rivals Read More »

dpatop - 13 December 2022, Berlin: Father Ziyad Salem takes care of his eight and a half month old son Omran Salem, who is in the intensive care unit of the children's clinic of St. Joseph's hospital with a respiratory infection and is receiving non-invasive ventilation (CPAP ventilation).  The children's clinic at St. Joseph's Hospital is heavily overloaded due to a surge in infections.  The situation is also difficult in other children's hospitals in Berlin.

FDA approves RSV drug to fight infection that kills thousands of children each year

Health From Brooke Steinberg July 18, 2023 | 11:26 The Food and Drug Administration on Monday approved a new drug, Beyfortus (nirsevimab), to protect children from the deadly infection known as respiratory syncytial virus. Worldwide, RSV is the second leading cause of death during the first year of an infant’s life, second only to malaria, …

FDA approves RSV drug to fight infection that kills thousands of children each year Read More »

image of the brain

Innovative Alzheimer’s drug slows disease: A new era for treatment

Medicinal From Marc Lallanilla July 17, 2023 | 10:53am In the battle against Alzheimer’s disease, experts are excited about a new weapon. A drug called donanemab, developed by Eli Lilly, has had a successful clinical trial and is expected to be approved by the Food and Drug Administration this fall. People taking donanemab had a …

Innovative Alzheimer’s drug slows disease: A new era for treatment Read More »

author['full_name']

After pushback, J&J authorizes generics of its tuberculosis drug

Following a campaign of public pressure, Johnson & Johnson (J&J) will allow a Swiss non-profit organization to supply generic bedaquiline (Sirturo) to low- and middle-income countries for the treatment of multidrug-resistant tuberculosis (TB). The campaign accused the global pharmaceutical maker of playing patent games to prevent wider distribution of the drug in low-income countries. The …

After pushback, J&J authorizes generics of its tuberculosis drug Read More »

A drug to prevent suicide associated with bipolar depression

A drug to prevent suicide associated with bipolar depression – ISRAEL21c

Every second of every day, someone in the world attempts suicide. NRx Pharmaceuticals is developing a drug for people whose suicidal thoughts stem from bipolar depression, the low mood phase associated with the severe mood swings of bipolar disorder. If clinical trials proceed as planned, the company hopes to bring the drug to market in …

A drug to prevent suicide associated with bipolar depression – ISRAEL21c Read More »

ADHD Treatment Drug Shortages Continue as Studies Point to Rising Prescriptions - Maryland Matters

ADHD Treatment Drug Shortages Continue as Studies Point to Rising Prescriptions – Maryland Matters

Federal drug agencies and pharmaceutical companies continue to report a shortage of common medications used to treat symptoms of attention-deficit/hyperactivity disorder. Stock.adobe.com photo by Alex DiStasi. Federal drug agencies and drug companies continue to report shortages of common drugs used to treat symptoms of attention deficit hyperactivity disorder (ADHD), even as recent studies show an …

ADHD Treatment Drug Shortages Continue as Studies Point to Rising Prescriptions – Maryland Matters Read More »

Scroll to Top